{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:34:04Z","timestamp":1793050444824,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004836","name":"Danmarks Frie Forskningsfond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jtha.2026.09.040","type":"journal-article","created":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T06:25:15Z","timestamp":1791008715000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["KRAS mutation and venous thromboembolism risk in colorectal cancer: a Danish population-based cohort study"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1447-0313","authenticated-orcid":false,"given":"Jannik","family":"Wheler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederikke Sch\u00f8nfeldt","family":"Troelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emese Katalin","family":"V\u00e1g\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erzs\u00e9bet","family":"Horv\u00e1th-Puh\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"van Es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Moik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cihan","family":"Ay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik Toft","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2026.09.040_bib1","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1056\/NEJM200012213432504","article-title":"Prognosis of cancers associated with venous thromboembolism","volume":"343","author":"S\u00f8rensen","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.09.040_bib2","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2007.02374.x","article-title":"Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy","volume":"5","author":"Khorana","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.09.040_bib3","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/sj.bjc.6605883","article-title":"Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997-2006","volume":"103","author":"Cronin-Fenton","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jtha.2026.09.040_bib4","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1182\/blood.2020007338","article-title":"Venous thromboembolism in cancer patients: a population-based cohort study","volume":"137","author":"Mulder","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.09.040_bib5","article-title":"Impact of venous thromboembolism on the mortality in patients with cancer: a population-based cohort study","volume":"34","author":"S\u00f8rensen","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.jtha.2026.09.040_bib6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41392-024-01907-z","article-title":"MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer","volume":"9","author":"Casacuberta-Serra","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jtha.2026.09.040_bib7","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1158\/0008-5472.CAN-06-0191","article-title":"KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer","volume":"66","author":"Li\u00e8vre","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtha.2026.09.040_bib8","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/sj.bjc.6603685","article-title":"Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by cetuximab plus chemotherapy","volume":"96","author":"Di Fiore","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jtha.2026.09.040_bib9","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1054\/bjoc.2001.1964","article-title":"Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study","volume":"85","author":"Andreyev","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jtha.2026.09.040_bib10","article-title":"Prognostic significance of KRAS, NRAS, BRAF, and PIK3CA mutations in stage II\/III colorectal cancer: a retrospective study and meta-analysis","volume":"20","author":"Kang","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.jtha.2026.09.040_bib11","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1002\/ijc.28153","article-title":"Promising biomarkers for predicting the outcomes of patients with KRAS wild-type metastatic colorectal cancer treated with anti-epidermal growth factor receptor monoclonal antibodies: a systematic review with meta-analysis","volume":"133","author":"Yang","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jtha.2026.09.040_bib12","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/annonc\/mdm496","article-title":"KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab","volume":"19","author":"De Roock","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtha.2026.09.040_bib13","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1200\/JCO.2007.14.7116","article-title":"Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer","volume":"26","author":"Amado","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtha.2026.09.040_bib14","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1055\/s-2006-933341","article-title":"Tissue factor in cancer and angiogenesis: the molecular link between genetic tumor progression, tumor neovascularization, and cancer coagulopathy","volume":"32","author":"Rak","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2026.09.040_bib15","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/jth.12910","article-title":"Tumor oncogene (KRAS) status and risk of venous thrombosis in patients with metastatic colorectal cancer","volume":"13","author":"Ades","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.09.040_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242316930","article-title":"The role of KRAS mutation in colorectal cancer-associated thrombosis","volume":"24","author":"Emilescu","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtha.2026.09.040_bib17","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1007\/s12094-020-02339-1","article-title":"Incidence of venous thromboembolism in patients with colorectal cancer according to oncogenic status","volume":"22","author":"Ortega Mor\u00e1n","year":"2020","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.jtha.2026.09.040_bib18","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2147\/CLEP.S179083","article-title":"The Danish health care system and epidemiological research: from health care contacts to database records","volume":"11","author":"Schmidt","year":"2019","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.jtha.2026.09.040_bib19","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","article-title":"The Danish Civil Registration System as a tool in epidemiology","volume":"29","author":"Schmidt","year":"2014","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jtha.2026.09.040_bib20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2147\/CLEP.S9908","article-title":"Existing data sources for clinical epidemiology: the Danish National Pathology Registry and Data Bank","volume":"2","author":"Erichsen","year":"2010","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.jtha.2026.09.040_bib21","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2147\/CLEP.S99481","article-title":"Danish Colorectal Cancer Group Database","volume":"8","author":"Ingeholm","year":"2016","journal-title":"Clin Epidemiol"},{"issue":"Suppl 7","key":"10.1016\/j.jtha.2026.09.040_bib22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/1403494810393562","article-title":"The Danish Cancer Registry","volume":"39","author":"Gjerstorff","year":"2011","journal-title":"Scand J Public Health"},{"key":"10.1016\/j.jtha.2026.09.040_bib23","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.jtha.2026.09.040_bib24","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2147\/CLEP.S509147","article-title":"Mental disorders in Danish Hospital Registers: a review of content and possibilities for epidemiological research","volume":"17","author":"Plana-Ripoll","year":"2025","journal-title":"Clin Epidemiol"},{"issue":"Suppl 7","key":"10.1016\/j.jtha.2026.09.040_bib25","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1403494810394717","article-title":"The Danish National Prescription Registry","volume":"39","author":"Wallach Kildemoes","year":"2011","journal-title":"Scand J Public Health"},{"key":"10.1016\/j.jtha.2026.09.040_bib26","year":"2025","journal-title":"Erbitux"},{"key":"10.1016\/j.jtha.2026.09.040_bib27","year":"2025","journal-title":"Vectibix"},{"key":"10.1016\/j.jtha.2026.09.040_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012832","article-title":"Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study","volume":"6","author":"Sundb\u00f8ll","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.jtha.2026.09.040_bib31","series-title":"TNM classification of malignant tumours","author":"Brierley","year":"2017"},{"key":"10.1016\/j.jtha.2026.09.040_bib32","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4103\/0019-5049.79879","article-title":"American Society of Anaesthesiologists physical status classification","volume":"55","author":"Daabiss","year":"2011","journal-title":"Indian J Anaesth"},{"key":"10.1016\/j.jtha.2026.09.040_bib33","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.jtha.2026.09.040_bib34","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1214\/aos\/1176344198","article-title":"Nonparametric estimation of partial transition probabilities in multiple decrement models","volume":"6","author":"Aalen","year":"1978","journal-title":"Ann Stat"},{"key":"10.1016\/j.jtha.2026.09.040_bib35","article-title":"An introduction to competing risks in epidemiology","volume":"18","author":"S\u00f8rensen","year":"2026","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.jtha.2026.09.040_bib36","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1182\/blood-2004-05-2042","article-title":"Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis","volume":"105","author":"Yu","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.09.040_bib37","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1161\/01.ATV.0000130465.23430.74","article-title":"Role of tissue factor in hemostasis, thrombosis, and vascular development","volume":"24","author":"Mackman","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2026.09.040_bib38","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/ajh.10061","article-title":"Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer","volume":"69","author":"Nakasaki","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2026.09.040_bib39","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1182\/blood.2020007488","article-title":"Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumors","volume":"137","author":"Dunbar","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.09.040_bib40","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.thromres.2022.02.022","article-title":"Association between genetic mutations and risk of venous thromboembolism in patients with solid tumor malignancies: a systematic review and meta-analysis","volume":"213","author":"Abufarhaneh","year":"2022","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.09.040_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/gcc.23236","article-title":"Temporal trends and regional variability in BRAF and KRAS genetic testing in Denmark (2010\u20132022): implications for precision medicine","volume":"63","author":"Frost","year":"2024","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.jtha.2026.09.040_bib43","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s12876-025-03843-w","article-title":"The impact of KRAS mutations on risk of venous thromboembolism recurrence in patients with metastatic colorectal cancer","volume":"25","author":"Liang","year":"2025","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jtha.2026.09.040_bib44","doi-asserted-by":"crossref","first-page":"264","DOI":"10.14740\/gr1062w","article-title":"Difference between left-sided and right-sided colorectal cancer: a focused review of literature","volume":"11","author":"Baran","year":"2018","journal-title":"Gastroenterol Res"},{"key":"10.1016\/j.jtha.2026.09.040_bib45","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3390\/biomedicines14020312","article-title":"Association of cancer-associated venous thromboembolism with the primary site of colorectal cancer, with respect to KRAS\/NRAS\/BRAF mutations","volume":"14","author":"Jovi\u0107 Zlatovi\u0107","year":"2026","journal-title":"Biomedicines"},{"key":"10.1016\/j.jtha.2026.09.040_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2024.109074","article-title":"Positive predictive value and sensitivity of cancer-associated venous thromboembolism diagnoses in the Danish National Patient Register","volume":"241","author":"Overvad","year":"2024","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.09.040_bib47","doi-asserted-by":"crossref","DOI":"10.1177\/10760296231196859","article-title":"Estimating venous thromboembolism risk in metastatic colorectal cancer inpatients: validation of existing risk scores and development of new risk scores","volume":"29","author":"Qin","year":"2023","journal-title":"Clin Appl Thromb Hemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626006306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626006306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:39:01Z","timestamp":1793047141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783626006306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":44,"alternative-id":["S1538783626006306"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2026.09.040","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"KRAS mutation and venous thromboembolism risk in colorectal cancer: a Danish population-based cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2026.09.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}